NO964533L - Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser - Google Patents

Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Info

Publication number
NO964533L
NO964533L NO964533A NO964533A NO964533L NO 964533 L NO964533 L NO 964533L NO 964533 A NO964533 A NO 964533A NO 964533 A NO964533 A NO 964533A NO 964533 L NO964533 L NO 964533L
Authority
NO
Norway
Prior art keywords
compounds
hetero
substituted amino
quinolone
antimicrobial compounds
Prior art date
Application number
NO964533A
Other languages
English (en)
Other versions
NO964533D0 (no
Inventor
Jr Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO964533D0 publication Critical patent/NO964533D0/no
Publication of NO964533L publication Critical patent/NO964533L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører antimikrobielle 5-(N-heterosubstituert amino)kinolonforbindelser som har en struktur i samsvar med formel (I) eller (II), hvori: (1) R1, R2, R3, R9 og R10 danner hvilken eller hvilke som helst av en rekke forskjellige kinolon- og beslektede heterocykliske strukturer lignende dem som er kjent innen fagområdet til å ha antimikrobiell aktivi- tet, og (2) (a) R4 og R5 er uavhengig hydrogen, lavere alkyl, cykloalkyl, heteroalkyl, eller -C(=0)-X-R8, hvor X er en kova- lent binding. N, O eller S, og R8 er lavere alkyl, lavere alkenyl, arylalkyl, en karbocyklisk ring, eller en hetero- cyklisk ring, eller (b) R4 og R5 sammen utgjør en hetero- cyklisk ring som inkluderer det nitrogen hvortil de er bundet, og de farmasøytisk akseptable salter, biohydrolyserbare estere, biohydrolyserbare amider, og solvater derav. Oppfin- nelsen vedrører også preparater omfattende disse forbindelser, såvel som metoder for behandling av infeksiøse lidelser ved anvendelse av forbindelsene og/eller preparatene i samsvar med den foreliggende oppfinnelse.
NO964533A 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser NO964533L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/235,003 US5646163A (en) 1992-10-30 1994-04-28 Quinolone 5-(N-heterosubstituted amino) antimicrobials
PCT/US1995/004495 WO1995029894A1 (en) 1994-04-28 1995-04-11 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials

Publications (2)

Publication Number Publication Date
NO964533D0 NO964533D0 (no) 1996-10-25
NO964533L true NO964533L (no) 1996-12-23

Family

ID=22883653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964533A NO964533L (no) 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Country Status (11)

Country Link
US (1) US5646163A (no)
EP (1) EP0757675A1 (no)
JP (1) JPH09512549A (no)
KR (1) KR100244992B1 (no)
CN (1) CN1157611A (no)
AU (1) AU2246695A (no)
BR (1) BR9507553A (no)
CA (1) CA2188918A1 (no)
FI (1) FI964318A (no)
NO (1) NO964533L (no)
WO (1) WO1995029894A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650203B1 (en) * 2000-09-11 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Process of preparation of benzimidazol-2-yl quinolinone derivatives
EP1664062B1 (en) * 2003-08-12 2013-03-13 Achillion Pharmaceuticals, Inc. Isothiazoloquinolones and related compounds as anti-infective agents
PL1666477T3 (pl) 2003-09-10 2013-11-29 Kyorin Seiyaku Kk Pochodna kwasu 7-(4-podstawionego-3-cyklopropyloaminometylo-1- pirolidynylo)chinolonokarboksylowego
WO2006020573A2 (en) * 2004-08-11 2006-02-23 Barbeau Donald L Noncardiotoxic pharmaceutical compounds
KR101289115B1 (ko) * 2004-08-13 2013-07-23 엠에스디 인터내셔널 홀딩즈 게엠베하 항생제인 트리아졸 및 코르티코스테로이드를 포함하는약제학적 제형
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
US7816406B2 (en) * 2004-09-17 2010-10-19 Cylene Pharmaceuticals, Inc. Quinolone analogs
EP1809639B1 (en) * 2004-11-11 2009-10-14 Achillion Pharmaceuticals, Inc. 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
WO2006074317A1 (en) * 2005-01-05 2006-07-13 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
US7199128B2 (en) 2005-02-02 2007-04-03 Achillion Pharmaceuticals, Inc. 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
US8114888B2 (en) * 2005-02-16 2012-02-14 Achillion Pharmaceuticals, Inc. Isothiazoloquinolones and related compounds as anti-infective agents
EP1913004B1 (en) 2005-07-27 2010-09-22 Achillion Pharmaceuticals, Inc. 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
PL1928887T3 (pl) * 2005-08-05 2015-05-29 Senhwa Biosciences Inc Sposoby otrzymywania analogów chinolonowych
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
WO2008143343A1 (ja) * 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
CA2756701A1 (en) * 2009-04-03 2010-10-07 Achillion Pharmaceuticals, Inc. Hydroxythienoquinolones and related compounds as anti-infective agents
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2011047323A2 (en) 2009-10-16 2011-04-21 Rib-X Pharmaceuticals, Inc. Antimicrobial compounds and methods of making and using the same
EP3421476A1 (en) 2009-10-16 2019-01-02 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
TWI618707B (zh) * 2009-10-16 2018-03-21 梅林塔療法公司 抗微生物性化合物，及製法及其用途
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
SG11201601654TA (en) 2013-09-09 2016-04-28 Melinta Therapeutics Inc Antimicrobial compunds and methods of making and using the same
CA2979342A1 (en) 2015-03-11 2016-09-15 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
WO2017193016A1 (en) 2016-05-06 2017-11-09 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2664950B2 (ja) * 1988-08-31 1997-10-22 日本電気株式会社 入出力処理装置
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones
DK0525057T3 (da) * 1990-04-18 2000-07-31 Procter & Gamble Pharma Antimikrobielle quinolonyllactamer
ES2101119T3 (es) * 1991-10-01 1997-07-01 Procter & Gamble Pharma Procedimiento para preparar quinolonil-lactamas antimicrobianas.
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
JPH09512549A (ja) 1997-12-16
CN1157611A (zh) 1997-08-20
KR970702849A (ko) 1997-06-10
FI964318A (fi) 1996-12-23
FI964318A0 (fi) 1996-10-25
EP0757675A1 (en) 1997-02-12
WO1995029894A1 (en) 1995-11-09
NO964533D0 (no) 1996-10-25
KR100244992B1 (ko) 2000-03-02
AU2246695A (en) 1995-11-29
US5646163A (en) 1997-07-08
CA2188918A1 (en) 1995-11-09
BR9507553A (pt) 1997-08-05

Similar Documents

Publication Publication Date Title
NO964533L (no) Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser
NO990551L (no) Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
NO331068B1 (no) Benzazepinderivater for behandling av nevrologiske forstyrrelser.
CA2256582A1 (en) Oxa acids and related compounds for treating skin conditions
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
NO951266L (no) Imidazol-holdige inhibitorer for farnesyl-protein-transferase
CA2157117A1 (en) Spirocyclic Piperidine Derivatives
HUT76476A (en) Morpholine and thiomorpholine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP0401886A2 (hu) Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
MXPA04001016A (es) Derivados de sulfonamida como inhibidores de la gamma secretasa.
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
EP1396493A4 (en) HETEROCYCLIC COMPOUNDS
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
NO951640L (no) Antimikrobielle 5-hydrazinokinolonderivater
NO20023251D0 (no) Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
NO995594L (no) Nye substituerte heterocykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
WO2005010154A3 (en) 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
WO2002046152A3 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
WO1998029407A3 (en) N-(pyridinylamino)isoindolines for treating alzheimer's and depression
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
KR960007560A (ko) 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도